Table 2

Clinical and demographic characteristics

VariableTotal (N=188)
n (%)
Age in months, median (IQR)10 (4.5–16)
 0–340 (21.3)
 4–1266 (35.1)
 >1282 (43.6)
Gender, male110 (58.5)
Diagnosis
 Rhinopharyngitis76 (40.4)
 Bronchiolitis54 (28.7)
 Croup32 (17.1)
 Wheezing23 (12.2)
 Pneumonia3 (1.6)
Time from first symptoms in days, median (IQR)3.5 (2–7)
 1–7143 (76)
 8–1424 (12.8)
 15–3021 (11.2)
Treatment decision
 Discharged66 (35.1)
 Short-term observation (<24 hours)67 (35.6)
 Hospital admission55 (29.3)
Viral isolation tested58 (30.8)
Negative35 (18.6)
 RSV17 (9)
 Adenovirus3 (1.6)
 Parainfluenza 12 (1.1)
 Adenovirus and RSV1 (0.5)
Length of stay in days, median (IQR)3 (2–5)
 0–7 178 (94.7)
 8–14 8 (4.3)
 15–302 (1)
Antibiotics prescribed9 (4.8)
PICU admission5 (2.7)
30-day mortality, n=1820
Return visit before 10 days25 (13.3)
 Discharged10 (5.3)
 Short-term observation (<24 hours)15 (7.9)
 Hospital admission0
  • n, absolute number or decimal; PICU, paediatric intensive care unit; RSV, respiratory syncytial virus.